Shaf Keshavjee MD

Shaf Keshavjee MD

University of Toronto

H-index: 99

North America-Canada

About Shaf Keshavjee MD

Shaf Keshavjee MD, With an exceptional h-index of 99 and a recent h-index of 43 (since 2020), a distinguished researcher at University of Toronto, specializes in the field of thoracic surgery, lung transplant, lung cancer.

His recent articles reflect a diverse array of research interests and contributions to the field:

Itaconate Supplementation in Preservation Solution Leads to Lung Function Improvement After Extended Hypothermic Preservation

Membraneless Perfusion-A Novel Technique for Ex Vivo Lung Perfusion

Dynamic Profiling of Endothelin-1 Levels During Ex Vivo Lung Perfusion Varies Across Donation Type and is Associated with Post-Transplant Outcome

Evaluating Effects of 10° C Preservation on Warm Ischemia Injured Lungs

ABO Genotype and its Relation on Histo-Blood Antigen Expression and Regeneration Following Removal-Potential Significance in ABO Incompatible Transplantation

Protective Effect of 10° C Storage on Donor Lungs with Lipopolysaccharide-Induced Acute Lung Injury

Extending the age criteria of lung transplant donors to 70+ years old does not significantly affect recipient survival

Fixative compositions and methods of preserving biological samples

Shaf Keshavjee MD Information

University

Position

Doctors of Thoracic Surgery, Toronto General Hospital, UHN

Citations(all)

34272

Citations(since 2020)

7763

Cited By

29505

hIndex(all)

99

hIndex(since 2020)

43

i10Index(all)

298

i10Index(since 2020)

173

Email

University Profile Page

Google Scholar

Shaf Keshavjee MD Skills & Research Interests

thoracic surgery

lung transplant

lung cancer

Top articles of Shaf Keshavjee MD

Itaconate Supplementation in Preservation Solution Leads to Lung Function Improvement After Extended Hypothermic Preservation

The Journal of Heart and Lung Transplantation

2024/4/1

Membraneless Perfusion-A Novel Technique for Ex Vivo Lung Perfusion

The Journal of Heart and Lung Transplantation

2024/4/1

Dynamic Profiling of Endothelin-1 Levels During Ex Vivo Lung Perfusion Varies Across Donation Type and is Associated with Post-Transplant Outcome

The Journal of Heart and Lung Transplantation

2024/4/1

Evaluating Effects of 10° C Preservation on Warm Ischemia Injured Lungs

The Journal of Heart and Lung Transplantation

2024/4/1

ABO Genotype and its Relation on Histo-Blood Antigen Expression and Regeneration Following Removal-Potential Significance in ABO Incompatible Transplantation

The Journal of Heart and Lung Transplantation

2024/4/1

Protective Effect of 10° C Storage on Donor Lungs with Lipopolysaccharide-Induced Acute Lung Injury

The Journal of Heart and Lung Transplantation

2024/4/1

Extending the age criteria of lung transplant donors to 70+ years old does not significantly affect recipient survival

The Journal of Thoracic and Cardiovascular Surgery

2024/3/1

Fixative compositions and methods of preserving biological samples

2023/11/30

EP07. 02-15 Longitudinal ctDNA Testing in Resected, Early Stage Non-small Cell Lung Cancers

Journal of Thoracic Oncology

2023/11/1

Methods, compositions, and systems for enhancing ex-vivo organ perfusion

2023/5/18

A Machine Learning Approach to Processing and Interpreting Ex Vivo Lung Radiographs Predicts Transplant Outcomes

The Journal of Heart and Lung Transplantation

2023/4/1

Biomarkers for detecting of outcome/risk of the patients with a respiratory illness

2023/3/30

Biomarker combinations in ex vivo lung perfusion (evlp) perfusate

2022/10/27

System and method for remote patient monitoring

2022/6/9

Standardized Radiographic Evaluation of Human Donor Lungs During Ex Vivo Lung Perfusion Predicts Lung Injury and Lung Transplant Outcomes

The Journal of Heart and Lung Transplantation

2022/4/1

The Inclusion of Biomarker Scoring During Ex-Vivo Lung Perfusion Can Improve Organ Utilization and Patient Outcomes-A Retrospective, Single Center Study

The Journal of Heart and Lung Transplantation

2022/4/1

Kinetic Modeling of Ex Vivo Lung Perfusion Biomarkers for the Prediction of Lung Transplant Outcomes

The Journal of Heart and Lung Transplantation

2022/4/1

Outcomes After Transplantation of Lungs Subjected to Prolonged Cold Ischaemic Time Following Ex-Vivo Lung Perfusion

The Journal of Heart and Lung Transplantation

2022/4/1

cfDNA Levels in Ex Vivo Lung Perfusate Are Associated with the Prognosis of Donor Lungs

The Journal of Heart and Lung Transplantation

2022/4/1

First North American Experience with Lung Transplantation from Donation After Medical Assistance in Dying

The Journal of Heart and Lung Transplantation

2022/4/1

See List of Professors in Shaf Keshavjee MD University(University of Toronto)